Hepatitis G Viral RNA in Serum and in Peripheral Blood Mononuclear Cells and Its Relation to HCV-RNA in Patients with Clotting Disorders

Summary

The hepatitis G virus (HGV) has recently been identified as a new member of the Flaviviridae family. Infection by this virus is thought to be associated with blood borne hepatitis. In this study, the presence of HCV- and HGV-RNAs in serum or plasma (175 patients) and in peripheral blood mononuclear cells (PBMC) (133 patients) was investigated in patients with clotting disorders using a sensitive reverse transcriptase polymerase chain reaction (RT-PCR). HGV-RNA was detected in serum of 26 patients (14.8%). In apparently healthy blood donors, serum HGV-RNA was detected in 4 of 358 individuals investigated (1.12%). Ninety two percent of the 26 serum HGV-RNA positive patients had coinfection with the hepatitis C virus (HGV), especially with HCV genotype lb, the most common genotype in Belgium. Of these coinfected patients, 15 (62.5%) showed elevated serum ALT levels. Two patients who were solely infected with HGV had normal serum ALT. HGV-RNA in PBMC was found in 18 patients, of whom 3 were negative for serum HGV-RNA. As in case of HCV, HGV-RNA in PBMC is preferentially sensitive to interferon treatment. Nevertheless, rapid reappearance of HGV-RNA in PBMC was observed after cessation of treatment. In one patient, persistent serum ALT elevation seems to be associated with continued HGV viremia, despite the disappearance of serum HCV-RNA.

• References

• 1 Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
• 2 Kuo G, Choo QL, Alter HJ, Gitnik GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364
• 3 Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral diseases. Hepatology 1991; 14: 381-388
• 4 Donahue JG, Munoz A, Ness PMBrown DE, Yawn DH, Mc AllisterHA, Reitz BA. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373
• 5 Linnen J, Wages Jr J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyalnis S, Karayiannis P, Fung K, Nakatsuj Y, Shih JW-K, Young L, Piatak Jr M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Founc SKH, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508
• 6 Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequence associated with human hepatitis. Nat Med 1995; 1: 564-569
• 7 Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL. Identification of two flavivirus-like genome in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405
• 8 Schmidt B, Korn K, Fieckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996; 347: 908
• 9 Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490
• 10 Willems M, Peerlinck K, Moshage H, Deleu I, Van denEynde C, Vermylen J, Yap SH. Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 1994; 42: 272-278
• 11 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-159
• 12 Sheng L, Willems M, Peerlinck K, Vermylen J, Yap SH. Hepatitis C virus genotypes in Belgian hemophiliacs. J Med Virol 1995; 45: 211-214
• 13 Czaja AJ, Carpenter HA, Santrach PJ, Breanndan M, Hombuger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterol 1993; 104: 1755-1761
• 14 Kudali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-1839
• 15 Nübling CM, Lӧwer J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin. Lancet 1996; 347: 68
• 16 Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 344: 195-196
• 17 Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132
• 18 Heringlake S, Osterkamp S, Trauwein C, Tillmann HL, Bӧker K, Muerhoff S, Mushahwar IK, Hunsmann G, Manns MP. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-1629
• 19 Jarvis LM, Davidso F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-1355
• 20 Garcia-Trevijano ER, López-Alcorocho JM, Quintana M, Hernández F, Carreño V. HGV in coagulation-factor concentrates. Lancet 1996; 348: 1032